Arkolith/Insider Trading/ABCL/Form 4

Montalbano John S.

DirectorAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed May 18, 2026
Net Buying
Open-Market Buys
$95K
Open-Market Sells
$0
Net Open-Market Flow
$95K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2026Buy(P)20K$4.77$95K241K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001834423-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML